ADARx Pharmaceuticals, Inc. (ADRX)
NASDAQ: ADRX · Real-Time Price · USD
17.95
-0.18 (-0.99%)
At close: Oct 28, 2026, 4:00 PM EDT
18.43
+0.48 (2.67%)
Pre-market: Oct 29, 2026, 4:00 AM EDT
ADARx Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, ADARx Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $34.25. The average 1-year stock price forecast is 90.81% higher than the current stock price, while the lowest is $32 (+78.27%) and the highest is $38 (+111.70%).
Price Target: $34.25 (+90.81%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for ADARx Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Initiates $38 | Buy | Initiates | $38 | +111.70% | Oct 20, 2026 |
| TD Cowen | TD Cowen | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Oct 20, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $32 | Buy | Initiates | $32 | +78.27% | Oct 20, 2026 |
| UBS | UBS | Buy Initiates $35 | Buy | Initiates | $35 | +94.99% | Oct 20, 2026 |
Financial Forecast
Revenue This Year
5.94M
from 3.45M
Increased by 72.35%
Revenue Next Year
39.87M
from 5.94M
Increased by 570.74%
EPS This Year
-1.68
EPS Next Year
-1.51
from -1.68
EPS and Forward PE are based on non-GAAP adjusted numbers.